Keyword :
Select Report Type :
Select Industry :
Select Sector :
Select Category :
Select Geography :

Search Results For Cardiovascular

Report Title
Price
Single User price :$13,007 Add To Cart
Enterprise Price :$14,006 Add To Cart
Global Corporate Price :$15,005 Add To Cart

 

India Coronary Stent and Angioplasty Market Through 2020 (Cath Lab Level Information—City, State and National)

-No one has covered cath labs in India like us: ABMRG

-Primary research covering 700 angioplasty centres in 150 cities

-Comparative analysis among states & regions; hospital chains; govt & pvt hospitals

http://www.abmrg.com/India-Coronary-Stent-and-Angioplasty-Market-Through-2020-Cath-lab-level-Information---City-State-and-National-.html

The coronary stent market in India, which comprises Drug Eluting Stent (DES), Bare Metal Stent (BMS) and Bio-Absorbable Stent (BVS), was valued above $400 million in 2012. DES accounts for bulk of sales in India. The bio-absorbable stent ABSORB has garnered a considerable traction despite its high cost compared with the other available DES. The key players operating in the segment are Alvimedica, Abbott Vascular, a division of Abbott Laboratories (NYSE : ABT), Boston Scientific (NYSE : BSX, LSE : BSX), Biosensors Inc., Biotronik, JW Medical, Medtronic, Inc. (NYSE :MDT), Meril Life Sciences, MicroPort Scientific Corporation (HKG: 0853), Sahajanand Medical Technologies and Translumina Therapeutics.

 

The market has grown impressively supported by a rise in coronary angioplasties which has resulted from a surge in cardiovascular diseases (CVDs), augmented healthcare spending as well as an increase in number of interventional cardiologists and cath labs in government and private hospitals, including individual cath lab centres run by interventional cardiologists as well as new corporate hospitals.

 

The demand has surged as central and state governments capped reimbursement rates which enhanced affordability resulting in an increase in volume. The decrease in reimbursement rates has given an edge to Indian, Asian and some of the Europe-based mid-sized MNCs which sell stents at almost half the price of those sold by US companies.

In the US, the stents market has slumped significantly due to negative results from clinical studies suggesting that one-third of stent implants are unnecessary. However, in India these studies have not made an impact as most Indian cardiologists do not seem to have taken these clinical outcomes seriously.

India Coronary Stent and Angioplasty Market Through 2020 (Cath Lab Level Information—City, State and National)’, is a market report published recently by ABMRG. It reviews historical trends and forecasts (between 2007 and 2020), annualised sales, market size (value and units), market growth, pricing, competitive landscape and market share.

The research report covers 700 cath labs across the country. It analyses angioplasty procedures’ (PCI and PTCA) data for the country with a detailed analysis at national, state, district, city and hospital levels. It provides PCI data of 550 hospitals from more than 150 cities. 

The report offers a proprietary cross-category comparison for products and geographies for the historical and forecast period. It also lists strategic developments in the global industry over the last two years, including M&As, partnerships, clinical studies, pipelines (R&D), product approvals and launches, recalls and litigations, market dynamics, market drivers and restraints.

Why one should buy this report - No one has covered cath labs in India like us.

The report can be instrumental in formulating strategic decisions to:

  • Make a regional strategy based on regional landscape and market characteristics.
  • Capitalise on opportunities in high-growth angioplasty regions/markets.
  • Plan capital investments based on the forecast for high angioplasty markets.
  • Prepare strategic presentations for the management, investors and shareholders.

Other strategic market reports: 

-          Global Coronary Stent Market Outlook Through 2019

http://www.abmrg.com/Global-Coronary-Stent-Market-Outlook-Through-2019.html

-          EU-7 Coronary Stents Market Outlook Through 2019

www.abmrg.com/EU-7-Coronary-Stents-Market-Outlook-Through-2019.html

-          European Interventional Cardiology Market through 2020

http://www.abmrg.com/European-Interventional-Cardiology-Market-through-2020.html

 

About ABMRG

ABMRG (Ace Business and Market Research Group) is a research and consulting firm focused on life sciences. It offers comprehensive research and analytical studies targeting various therapeutic sectors and its market dynamics, vital trends, business strategies and clinical pipeline. Its cutting edge reports empower companies to make smarter, effective and faster strategic decisions for business growth.

Contact:

Ankit Jian - sales@abmrg.com ; 19@abmrg.com

+91 – 8238155239; +91 - 261-2216406

Source: ABMRG

India Coronary Stents Market - Potential & Growth Forecast to 2019 (2nd Edition)   $13,834
  • Language: English | #Pages: 157 | Published: Feb-2015 | Region: Global
Single User price :$13,834 Add To Cart
Enterprise Price :$13,834 Add To Cart
Global Corporate Price :$13,834 Add To Cart

 India Coronary Stent Market Would Continue to Grow in Double Digits and Abbott Vascular  to Lead the Market 

The coronary stent market in India was valued around $450 million in 2012 and it has grown at an impressive rate of 22% (2005-2012) backed by a rise in PCIs (Percutaneous Coronary Intervention) which is resulted from a surge in cardiovascular disease (CVD), an improvement in healthcare infrastructure and services and an increase in disposable income. An increasing penetration of DES, which is above 90%, has also boosted the market.

The market is lead by Abbott Vascular, followed by Boston Scientific. Other key players operating in the segment are Medtronic, Inc., Biotronik, Sahajanand Medical Technologies, Meril Life Sciences and Translumina Therapeutics. Johnson and Johnson's Cordis stopped selling its stents from 20011. Cordis's market was grabbed by Abbott, Medtronic and other players. Bioabsorbable stent ABSORB, which was recently launched by Abbott Vascular, has garnered a considerable traction among the medical fraternity despite its high cost compared with other stents available in the market. The patients opting for ABSORB are financially sound or have either health insurance or are entitled for reimbursement. Abbott is aggressively chasing the market through a direct-to-consumer approach (DTC).
 
The coronary stent market in the country will continue to grow at a faster pace due to new and upcoming private hospitals, government initiatives to improve healthcare access, an increasing number of interventional cardiologists, an explosion of healthcare insurance and a growth in usage of high value bioabsorbable stents. The anticipated progression can be attributed to growth in elderly population, improved life expectancy, lifestyle diseases and associated complications like diabetes, hypertension and obesity.
 
The majority of population in need of stents is not covered under health insurance or do not get reimbursements which limits the market. However, patients under the poverty line are sponsored for healthcare insurance through the state government or insurance under public and private partnership. Some state governments have put a cap on the pricing of stents; though it may limit the market in terms of value but may help increase penetration of stents. Some state governments have put a cap on the value of stents; though this may help increase penetration of stents, it may limit the market in terms of value.
Meanwhile, the market is crowded with local players. Also, Europe-based mid-sized companies sell stents at almost half the price of international brands. It makes the market more competitive for MNCs. Further, the reduction in the reimbursement rates under the Central Government Health Scheme (CGHS) is likely to force companies to lower prices in the market.  
 
However, the main restraints to market growth are high device and procedure costs and a lack of skilled interventional cardiologists. Hospitals and distributors in the supply chain make a killing as the device is mostly used in patients for emergency treatment.
The recently published strategic market report by ABMRG, "India coronary stent market-potential and growth forecast to 2019", analyzes the coronary stent market in India. It reviews historical trends and forecasts (2005-2019) the annualized trends for sales in terms of value and volume, market growth, pricing (Average Selling Price or ASP), competitive landscape and market share. It outlines coronary pipeline products and highlights findings of the global clinical studies. It offers a cross-category comparison for the historical and forecast period. It also provides global industry developments for the last two years, including M&As, partnerships, clinical studies, pipeline, product approvals and launches, recalls and litigations, market dynamics and market drivers.
Global Interventional Cardiology Market Through 2020   $9,200
  • Language: English | #Pages: 506 | Published: Oct-2014 | Region: Global
Single User price :$9,200 Add To Cart
Enterprise Price :$18,400 Add To Cart
Global Corporate Price :$27,600 Add To Cart
This research report provides key market trends, market forecasts and competitive scenario of the Global Interventional Cardiology through 2020. The countries covered in this report are EU7+ Poland, Austria, Switzerland, Russia, Ukraine, Czech Republic, Bulgaria, Greece, Hungary, Romania, Norway, Denmark and Sweden, APAC – India, China, Australia, Japan, Korea, NA – US and Canada, SCA – Mexico, Brazil, Argentina.
 
The product categories covered in this report include: 
Coronary Stent
PTCA Balloon
Arteriotomy Closure Devices (ACDs)
 
Scope
The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. 
Highlights and compares key product categories for growth trends and revenue forecast.
Market size, annualized revenue and unit sales for each product category from 2007 to 2020.
Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2018. 
Market share of companies.
Average selling price ($) for each product type (2007 to 2020).
Recent events and developments.
 
Why should you buy?
Build business strategy by identifying the high growth and attractive market categories. 
Develop competitive strategy based on competitive landscape. 
Design capital investment strategies based on forecasted high potential segments. 
Identify potential business partners, acquisition targets and business buyers. 
Plan for a new product launch and inventory in advance. 
Prepare management and strategic presentations using the market data. 

To review unbiased and independent assessment of the market data. 

European Interventional Cardiology Market through 2020   $8,300
  • Language: English | #Pages: 150 | Published: Oct-2014 | Region: Global
Single User price :$8,300 Add To Cart
Enterprise Price :$16,600 Add To Cart
Global Corporate Price :$24,900 Add To Cart

This research report provides key market trends, market forecasts and competitive scenario of the European Interventional Cardiology in Europe through 2020. The countries covered in this repot are EU7+ Poland, Austria, Switzerland, Russia, Ukraine, Czech Republic, Bulgaria, Greece, Hungary, Romania, Norway, Denmark and Sweden.

The product categories covered in this report include: 

Coronary Stent

PTCA Balloon

Arteriotomy Closure Devices (ACDs)

 

Scope

The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. 

Highlights and compares key product categories for growth trends and revenue forecast.

Market size, annualized revenue and unit sales for each product category from 2007 to 2020.

Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2020. 

Market share of companies.

Average selling price ($) for each product type (2007 to 2020).

Recent events and developments.

 

Why should you buy?

Build business strategy by identifying the high growth and attractive market categories. 

Develop competitive strategy based on competitive landscape. 

Design capital investment strategies based on forecasted high potential segments. 

Identify potential business partners, acquisition targets and business buyers. 

Plan for a new product launch and inventory in advance. 

Prepare management and strategic presentations using the market data. 

To review unbiased and independent assessment of the market data.

Interventional Cardiology Market- Eastern And Central Europe through 2020   $7,200
  • Language: English | #Pages: 110 | Published: Oct-2014 | Region: Global
Single User price :$7,200 Add To Cart
Enterprise Price :$14,400 Add To Cart
Global Corporate Price :$21,600 Add To Cart
This research report provides key market trends, market forecasts and competitive scenario of the Eastern and Central Interventional Cardiology through 2020. The countries covered in this report are Russia, Ukraine, Czech republic, Austria, Hungary, Poland, Romania, Bulgaria, Greece.
 
 
The product categories covered in this report include: 
Coronary Stent
PTCA Balloon
Arteriotomy Closure Devices (ACDs)
 
Scope
The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. 
Highlights and compares key product categories for growth trends and revenue forecast.
Market size, annualized revenue and unit sales for each product category from 2007 to 2020.
Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2018. 
Market share of companies.
Average selling price ($) for each product type (2007 to 2020).
Recent events and developments.
 
Why should you buy?
Build business strategy by identifying the high growth and attractive market categories. 
Develop competitive strategy based on competitive landscape. 
Design capital investment strategies based on forecasted high potential segments. 
Identify potential business partners, acquisition targets and business buyers. 
Plan for a new product launch and inventory in advance. 
Prepare management and strategic presentations using the market data. 

To review unbiased and independent assessment of the market data. 

Europe Coronary Stents Market Outlook Through 2019   $7,210
  • Language: English | #Pages: 120 | Published: Sep-2014 | Region: Global
Single User price :$7,210 Add To Cart
Enterprise Price :$14,420 Add To Cart
Global Corporate Price :$21,630 Add To Cart

This research report provides key market trends, market forecasts and competitive scenario of the Coronary Stents in the Europe through 2019. 

 
Scope
- The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. 
- Highlights and compares key product categories for growth trends and revenue forecast.
- Market size, annualized revenue and unit sales for each product category from 2006 to 2019.
- Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2019. 
- Market share of companies.
- Average selling price ($) for each product type (2006 to 2019).
- Detailed pipeline and clinical studies.
- Recent events and developments,
 
Why should you buy?
- Build business strategy by identifying the high growth and attractive market categories. 
- Develop competitive strategy based on competitive landscape. 
- Design capital investment strategies based on forecasted high potential segments. 
- Identify potential business partners, acquisition targets and business buyers. 
- Plan for a new product launch and inventory in advance. 
- Prepare management and strategic presentations using the market data. 
- To review unbiased and independent assessment of the market data.
EU-7 Coronary Stents Market Outlook Through 2019   $6,310
  • Language: English | #Pages: 103 | Published: Sep-2014 | Region: Global
Single User price :$6,310 Add To Cart
Enterprise Price :$12,620 Add To Cart
Global Corporate Price :$18,930 Add To Cart

This research report provides key market trends, market forecasts and competitive scenario of the Coronary Stents in the EU-7 through 2019. 

Scope

- The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. 

- Highlights and compares key product categories for growth trends and revenue forecast.

- Market size, annualized revenue and unit sales for each product category from 2006 to 2019.

- Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2019. 

- Market share of companies.

- Average selling price ($) for each product type (2006 to 2019).

- Detailed pipeline and clinical studies.

- Recent events and developments,

Why should you buy?

- Build business strategy by identifying the high growth and attractive market categories. 

- Develop competitive strategy based on competitive landscape. 

- Design capital investment strategies based on forecasted high potential segments. 

- Identify potential business partners, acquisition targets and business buyers. 

- Plan for a new product launch and inventory in advance. 

- Prepare management and strategic presentations using the market data. 

- To review unbiased and independent assessment of the market data. 

 
EU-5 Coronary Stents Market Outlook Through 2019   $5,810
  • Language: English | #Pages: 90 | Published: Sep-2014 | Region: Global
Single User price :$5,810 Add To Cart
Enterprise Price :$11,620 Add To Cart
Global Corporate Price :$17,430 Add To Cart
This research report provides key market trends, market forecasts and competitive scenario of the Coronary Stents in the EU-5 through 2019. 
 
 
Scope
- The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. 
- Highlights and compares key product categories for growth trends and revenue forecast.
- Market size, annualized revenue and unit sales for each product category from 2006 to 2019.
- Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2019. 
- Market share of companies.
- Average selling price ($) for each product type (2006 to 2019).
- Detailed pipeline and clinical studies.
- Recent events and developments,
 
Why should you buy?
- Build business strategy by identifying the high growth and attractive market categories. 
- Develop competitive strategy based on competitive landscape. 
- Design capital investment strategies based on forecasted high potential segments. 
- Identify potential business partners, acquisition targets and business buyers. 
- Plan for a new product launch and inventory in advance. 
- Prepare management and strategic presentations using the market data. 
- To review unbiased and independent assessment of the market data. 
 
 
 

 

UK Coronary Stents Market Trends Forecast To 2019   $2,900
  • Language: English | #Pages: 30 | Published: Aug-2014 | Region: UK
Single User price :$2,900 Add To Cart
Enterprise Price :$5,800 Add To Cart
Global Corporate Price :$8,700 Add To Cart

This research report provides key market trends, market forecasts and competitive scenario of the Coronary Stents in the UK through 2019. 

It provides data at country level

- Market size of coronary stents in terms - value and volume (2005-2019) for BMS, DES and Bioabsorbables (BVS) 

- Market growth rates (2005-2019)

- Average prices of various stents (2005-2019)

- Number of PCI procedures

- Market dynamics – market trends, drivers, restrains, issues, competitive landscape

- Detailed pipeline and clinical studies  

Scope

- The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. 

- Highlights and compares key product categories for growth trends and revenue forecast.

- Market size, annualized revenue and unit sales for each product category from 2006 to 2019.

- Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2019. 

- Market share of companies.

- Average selling price ($) for each product type (2006 to 2019).

Why should you buy?

- Build business strategy by identifying the high growth and attractive market categories. 

- Develop competitive strategy based on competitive landscape. 

- Design capital investment strategies based on forecasted high potential segments. 

- Identify potential business partners, acquisition targets and business buyers. 

- Plan for a new product launch and inventory in advance. 

- Prepare management and strategic presentations using the market data. 

- To review unbiased and independent assessment of the market data. 

Germany Coronary Stents Market Trends Forecast To 2019   $2,900
  • Language: English | #Pages: 30 | Published: Aug-2014 | Region: Germany
Single User price :$2,900 Add To Cart
Enterprise Price :$5,800 Add To Cart
Global Corporate Price :$8,700 Add To Cart

This research report provides key market trends, market forecasts and competitive scenario of the Coronary Stents in Germany through 2019. 

It provides data at country level
- Market size of coronary stents in terms - value and volume (2005-2019) for BMS, DES and Bioabsorbables (BVS) 
- Market growth rates (2005-2019)
- Average prices of various stents (2005-2019)
- Number of PCI procedures
- Market dynamics – market trends, drivers, restrains, issues, competitive landscape
- Detailed pipeline and clinical studies  
 
Scope
- The report highlights historic and forecasted market size in terms of revenues & unit sales, average selling price, growth rates, and company market shares. 
- Highlights and compares key product categories for growth trends and revenue forecast.
- Market size, annualized revenue and unit sales for each product category from 2006 to 2019.
- Cross category comparison - Growth and revenue comparison for product categories, historic and forecast through 2019. 
- Market share of companies.
- Average selling price ($) for each product type (2006 to 2019).
 
Why should you buy?
- Build business strategy by identifying the high growth and attractive market categories. 
- Develop competitive strategy based on competitive landscape. 
- Design capital investment strategies based on forecasted high potential segments. 
- Identify potential business partners, acquisition targets and business buyers. 
- Plan for a new product launch and inventory in advance. 
- Prepare management and strategic presentations using the market data. 
- To review unbiased and independent assessment of the market data. 
 

 1    2   | 3   | 4   | 5   | >   | >>   

Page 1 of 11   showing records 1 to 10 of 109 in this selection